Study: Hearing Loss Disproportionately Impacts People of Color
Findings by David Nadler, Ph.D., highlight hearing loss as a public health issue and may help employers reduce this occupational hazard in an ever-evolving and more diverse workforce.
NYITCOM Honors Alumni and Friends
On May 2, the College of Osteopathic Medicine (NYITCOM) recognized seven alumni and supporters for their positive impact on the education of future physicians and significant contributions to the field of medicine at its annual Alumni Awards held at NYIT de Seversky Mansion.
Making Heads or Tails of Helmet Safety
A new study by NYITCOM researchers explores how helmet design may play a role in limiting concussion severity.
Study: Spice May Improve Ovarian Cancer Treatment
New research by NYITCOM’s Maria Pino, Ph.D., makes the case for why curcumin could help enhance treatment for ovarian cancer.
Turning the Tables on Consumers
A study co-authored by marketing researcher Colleen Kirk, D.P.S., explores what happens when sellers review consumers.
The Scent of Discovery
New research from the College of Osteopathic Medicine (NYITCOM) could help explain how the sense of smell is impacted in individuals with autism.
A Quest for Bacterial Assassins
The College of Arts and Sciences’ Bryan Gibb, Ph.D., and undergraduate Hamza Nawargala are working on research to combat antibiotic-resistant infections.
Keeping Science on Its Toes
In a study published by PeerJ, Professor Nikos Solounias, Ph.D., and NYITCOM student Shannon Smith explain why a bony structure—which they dub “the bony cap”—may play a large role in finger and toe regeneration and nail growth.
A Research Collaboration with Heart
NYITCOM and the DeMatteis Center for Cardiac Research and Education have forged a new collaboration that enables medical students to join in innovative and potentially life-saving research.
NIH-Funded Research at NYITCOM Could Yield New Brain Disorder Treatments
NYITCOM’s Jerry Zhao, Ph.D., has secured an NIH grant in support of research that could help to deliver new drugs to treat Alzheimer’s disease, Parkinson’s disease, and autism spectrum disorder.